GGrantIndex
← Leaderboards

John W Sleasman

University Of Florida

$11,039,991
Attributed
$12,773,970
Total exposure
6
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY200625
$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$12,773,970 · 6

By mechanism

R01$5,390,701 · 2
T32$4,029,874 · 1
U01$2,910,645 · 1
R21$442,750 · 1
M01$0 · 1

Top collaborators

Most similar at University Of Florida

Same institution · by research overlap

Others in their field

Top investigators on “Immune

Research focus

ImmuneImmunityCd4 Positive T LymphocytesAffectInfectionInflammatoryHiv InfectionsImmune ResponseDeep SequencingCohortAntiretroviral TherapyViralComplexResearch TrainingInnovationMacrophage ActivationClinical ImmunologyImmune ActivationHiv-1ResponseHypersensitivityT-LymphocyteChildPeripheral Blood

Grant awards (34)

Research Training in Allergy and Clinical Immunology$486,806
T32 · FY2025 · AI
Research Training in Allergy and Clinical Immunology$400,879
T32 · FY2024 · AI
Research Training in Allergy and Clinical Immunology$443,911
T32 · FY2023 · AI
Research Training in Allergy and Clinical Immunology$424,259
T32 · FY2022 · AI
Consequences of marijuana use on inflammatory pathways in HIV-infected youth$542,130
U01 · FY2021 · DA · contact PI
Impact of maternal HIV infection on immune priming of their uninfected infants$161,000
R21 · FY2021 · HD · contact PI
Consequences of marijuana use on inflammatory pathways in HIV-infected youth$673,175
U01 · FY2020 · DA · contact PI
Research Training in Allergy and Clinical Immunology$325,292
T32 · FY2020 · AI · contact PI
Impact of maternal HIV infection on immune priming of their uninfected infants$281,750
R21 · FY2020 · HD · contact PI
Consequences of marijuana use on inflammatory pathways in HIV-infected youth$544,996
U01 · FY2019 · DA · contact PI
Research Training in Allergy and Clinical Immunology$352,781
T32 · FY2019 · AI · contact PI
Consequences of marijuana use on inflammatory pathways in HIV-infected youth$582,994
U01 · FY2018 · DA · contact PI
Research Training in Allergy and Clinical Immunology$349,474
T32 · FY2018 · AI · contact PI
Consequences of marijuana use on inflammatory pathways in HIV-infected youth$567,350
U01 · FY2017 · DA · contact PI
Research Training in Allergy and Clinical Immunology$313,430
T32 · FY2017 · AI · contact PI
Effect of breast feeding on immunologic priming in young infants.$477,000
R01 · FY2016 · AI · contact PI
Research Training in Allergy and Clinical Immunology$371,126
T32 · FY2016 · AI · contact PI
Effect of breast feeding on immunologic priming in young infants.$636,143
R01 · FY2015 · AI · contact PI
Research Training in Allergy and Clinical Immunology$199,681
T32 · FY2015 · AI · contact PI
Effect of breast feeding on immunologic priming in young infants.$446,792
R01 · FY2014 · AI · contact PI
Research Training in Allergy and Clinical Immunology$169,915
T32 · FY2014 · AI · contact PI
Effect of breast feeding on immunologic priming in young infants.$340,616
R01 · FY2013 · AI · contact PI
Research Training in Allergy and Clinical Immunology$192,320
T32 · FY2013 · AI · contact PI
Effect of breast feeding on immunologic priming in young infants.$95,270
R01 · FY2013 · AI · contact PI
Effect of breast feeding on immunologic priming in young infants.$473,130
R01 · FY2012 · AI · contact PI
Impact of HIV-1 Genotype on Therapy Response in Children$447,567
R01 · FY2010 · AI · contact PI
Impact of HIV-1 Genotype on Therapy Response in Children$442,547
R01 · FY2009 · AI · contact PI
Impact of HIV-1 Genotype on Therapy Response in Children$433,202
R01 · FY2008 · AI · contact PI
Impact of HIV-1 Genotype on Therapy Response in Children$432,364
R01 · FY2007 · AI · contact PI
Impact of HIV-1 Genotype on Therapy Response in Children$447,000
R01 · FY2006 · AI · contact PI
IMPACT OF HIV-1 GENOTYPE ON THERAPY RESPONSE IN CHILDREN$359,688
R01 · FY2002 · AI
IMPACT OF HIV-1 GENOTYPE ON THERAPY RESPONSE IN CHILDREN$359,382
R01 · FY2001 · AI
PHASE II TRIAL OF SAQUINAVIR REGIMEN IN PEDIATRIC AIDS$0
M01 · FY2000 · RR
PHASE II TRIAL OF SAQUINAVIR REGIMEN IN PEDIATRIC AIDS$0
M01 · FY2000 · RR